Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000676

Sagent Pharmaceuticals, Inc. · SGNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Nov 2, 2015
Accepted (ET)
Nov 4, 2015 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Nov 2, 2015S92,843$16.8695D4,057,543ISee footnote (3)
Common StockF1,F4Nov 2, 2015S680$16.8695D29,725ISee footnote (4)
Common StockF2,F5Nov 3, 2015S66,793$16.32D3,990,750ISee footnote (5)
Common StockF2,F6Nov 3, 2015S490$16.32D29,235ISee footnote (6)
Common StockF7Nov 4, 2015S532,119$15.45D3,458,631ISee footnote (7)
Common StockF8Nov 4, 2015S3,898$15.45D25,337ISee footnote (8)

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses